SCHEMBL19655290

SCHEMBL19655290

c1ccc(-c2nc3ccccc3nc2-n2c3ccccc3c3cc4c(cc32)c2ccccc2n4-c2cccc3c2sc2ccccc23)cc1

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD17B10 Q99714 3/20 0.34
CASP1 P29466 1/20 0.34
HRH4 Q9H3N8 1/20 0.34
TNKS O95271 1/20 0.33
TNKS2 Q9H2K2 1/20 0.33
ALOX5 P09917 1/20 0.33
KDM4E B2RXH2 3/20 0.33
HPGD P15428 2/20 0.33
ALDH1A1 P00352 2/20 0.33
GAA P10253 1/20 0.33
MEN1 O00255 1/20 0.31
POLB P06746 1/20 0.31
KMT2A Q03164 1/20 0.31
NPC1 O15118 1/20 0.31
LMNA P02545 1/20 0.31
TP53 P04637 1/20 0.31
RAB9A P51151 1/20 0.31
SMN1; SMN2 Q16637 1/20 0.31
GSR P00390 1/20 0.31
HTT P42858 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19655294 0.98 ALOX5 (0.34) HSD17B10CASP1HRH4TNKSTNKS2
SCHEMBL19653897 0.90 HSD17B10 (0.34) HSD17B10CASP1HRH4TNKSTNKS2
SCHEMBL19655293 0.90 LIMK1 (0.34) HSD17B10CASP1HRH4KDM4EHPGD
SCHEMBL19655351 0.89 TNKS (0.33) TNKSTNKS2ALOX5PRKDCMAPT
SCHEMBL19655172 0.88 HSD17B10 (0.34) HSD17B10CASP1HRH4TNKSTNKS2
SCHEMBL19653901 0.88 HSD17B10 (0.33) HSD17B10CASP1HRH4TNKSTNKS2
SCHEMBL19655315 0.88 L3MBTL1 (0.33) HSD17B10TNKSTNKS2ALOX5KDM4E
SCHEMBL24104960 0.87 ALOX5 (0.45) HSD17B10CASP1HRH4TNKSTNKS2
SCHEMBL19655186 0.87 HSD17B10 (0.33) HSD17B10CASP1HRH4TNKSTNKS2
SCHEMBL21941898 0.86 HRH4 (0.40) HSD17B10CASP1HRH4KDM4EHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10840458-B2 Organic electroluminescent materials and devices UNIVERSAL DISPLAY CORPORATION (US) 2020-11-17 US disclosed
US-20170346022-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES UNIVERSAL DISPLAY CORPORATION (US) 2017-11-30 US disclosed
US-20170346022-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES UNIVERSAL DISPLAY CORPORATION (US) 2017-11-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170346022-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES PDXK, MT-ND4L, PNPO HSD17B10 3487/4885CASP1 3467/4885HRH4 1559/4885
US-10840458-B2 Organic electroluminescent materials and devices PDXK, MT-ND4L, PNPO HSD17B10 3487/4885CASP1 3467/4885HRH4 1559/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.